“The bacteria effectively hide in a bunker”: New research reveals a surprising mechanism used by Acinetobacter baumannii and Pseudomonas aeruginosa to protect themselves from antibiotics.
To better distinguish between healthy and diseased gut microbiomes, scientists have created an index that tracks microbial behavior and signals conditions such as colorectal cancer.
A research team led by the University of Waterloo is developing a novel tool to treat cancer by engineering hungry bacteria to literally eat tumours from the inside out.
Researchers have uncovered how a high-risk class of genetic vectors can efficiently spread antibiotic resistance within the gut, enabling even highly virulent bacteria to acquire drug resistance.
Chemotherapy does more than kill cancer cells: It reshapes the gut microbiome, making the body less permissive to metastasis. This finding opens new avenues for adjuvant strategies.
Now, a research team has developed a novel diagnostic approach that enables the rapid and simultaneous detection of both antibiotic resistance and high virulence in Klebsiella pneumoniae.
New research shows that a harmless strain of Klebsiella – discovered by chance in laboratory experiments – can eliminate infections and reduce gut inflammation in inflammatory bowel disease (IBD).
From volcanic activity to the deaths of millions: Using climate data and documentary evidence, researchers have painted a detailed picture of how the Black Death pandemic reached Europe.
Microplastics pose a human health risk in more ways than one, a new study reveals: not only do the particles harbor pathogenic bacteria, they may also help the spread of antimicrobial resistance.
Pseudomonas aeruginosa, a hospital-acquired bacterium that causes serious infections, can move from the lungs to the gut inside the same patient, raising the risk of sepsis, new research reveals.
A team of researchers comprehensively catalogued a new collection of bacteria-eating viruses called phages. These phages could be used to combat Klebsiella pneumoniae - a serious threat in hospitals.
An innovative Group A Streptococcus “One-Step Antigen Extraction + Detection” Kit (immunochromatography), developed by GenSure Biotech Inc., has successfully obtained both Class B and Class C EU IVDR certifications for in vitro diagnostic medical devices.
Researchers have discovered a previously unknown mechanism that explains how bacteria within a tumor can drive treatment resistance in patients with oral and colorectal cancer.
Scientists are on the way to finding a vaccine to fight off Helicobacter pylori - a bacterium found in over 60% of people - possibly preventing stomach ulcers and lowering the risk for stomach cancer.
When the many protect the few: An expert explains the premise of herd immunity, and how vaccinations apply the priciple in preventing communicable diseases, notably in the complete eradication of smallpox.
An unexpected trigger for heart attack: Researchers show that dormant bacteria can contribute to atherosclerotic plaques and fatal myocardial infarction, effectively making it an infectious disease.
Scientists developed an AI-based approach to diagnose colorectal cancer from different microbial subgroups in the gut microbiota – a non-invasive and low-cost alternative to colonoscopy screening.
The vaginal microbiome is a largely overlooked area of medicine that could dramatically improve outcomes for common infections, infertility and even cancer for millions of women, a new review finds.
A new, bacteria-based contrast agent illuminates tumors like a neon sign during surgery, enabling more precise resection and reducing the risk of recurrence.
